Ceftazidime Injection – Advanced Third-Generation Cephalosporin for Critical Infections

Introduction

• Ceftazidime Injection is a widely used third-generation cephalosporin antibiotic.
• It works by inhibiting bacterial cell wall synthesis, leading to bacterial death.
• Identified by CAS Number 72558-82-8, it is highly effective against gram-negative pathogens.
• Widely used in hospitals for serious and resistant infections.
• Manufactured under strict global pharmaceutical standards.

Important Information

• Belongs to third-generation cephalosporin class.
• CAS 72558-82-8 ensures traceability.
• Available in 250mg, 500mg, 1g, and 2g strengths.
• Injectable powder for reconstitution.
• Requires strict medical supervision.

Dosage

Storage

• Store below 25°C
• Protect from light and moisture
• Use reconstituted solution within recommended time
• Keep out of reach of children

Shelf Life

• Unopened vial: 24–36 months
• After reconstitution: use as per guidelines
• Check expiry before use

Manufacturing

• Manufactured in WHO-GMP certified facilities
• High-purity API (CAS 72558-82-8)
• Sterile injectable manufacturing process
• Lyophilization technology for stability
• Multi-stage quality control testing
• Compliance with WHO-GMP and EU-GMP standards

Precautions

• Check for cephalosporin or penicillin allergy
• Use cautiously in renal impairment
• Monitor kidney function
• Avoid unnecessary prolonged use
• Use in pregnancy only if prescribed
• Monitor for superinfection

Side Effects

• Injection site pain
• Nausea
• Vomiting
• Diarrhea
• Rash
• Fever
• Headache
• Rare kidney dysfunction
• Rare allergic reactions

Expert View

• Highly effective hospital-grade antibiotic.
• Strong activity against gram-negative bacteria.
• Preferred for Pseudomonas infections.
• Reliable in ICU settings.
• Globally accepted cephalosporin therapy.

Indications

• Severe respiratory infections (pneumonia)
• Complicated urinary tract infections
• Skin and soft tissue infections
• Bone and joint infections
• Septicemia
• Meningitis
• Intra-abdominal infections
• Hospital-acquired infections

Maintenance

• Treatment duration: 5–14 days
• Adjust dose in renal impairment
• Monitor during prolonged therapy
• Complete full course
• Follow physician guidance

Why Choose

• Advanced cephalosporin therapy
• WHO-GMP certified manufacturing
• Strong gram-negative coverage
• Reliable ICU-grade formulation
• Global export-quality standards